Navigation Links
Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052)
Date:5/12/2011

WASHINGTON, May 12, 2011 /PRNewswire-USNewswire/ -- Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners through initiation of oral antiretroviral therapy (ART), according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network (HPTN), a global partnership dedicated to reducing the transmission of HIV through cutting-edge biomedical, behavioral, and structural interventions.

The study, known as HPTN 052, was designed to evaluate whether immediate versus delayed use of ART by HIV-infected individuals would reduce transmission of HIV to their HIV-uninfected partners and potentially benefit the HIV-infected individual as well. Findings from the study were reviewed by an independent Data and Safety Monitoring Board (DSMB).The DSMB recommended that the results be released as soon as possible and that the findings be shared with study participants and investigators. The DSMB concluded that initiation of ART by HIV-infected individuals substantially protected their HIV-uninfected sexual partners from acquiring HIV infection, with a 96 percent reduction in risk of HIV transmission. HPTN 052 is the first randomized clinical trial to show that treating an HIV-infected individual with ART can reduce the risk of sexual transmission of HIV to an uninfected partner.

"This is excellent news," said Dr. Myron Cohen, HPTN 052 Principal Investigator and Associate Vice Chancellor for Global Health and Director of the Institute of Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill. "The study was designed to evaluate the benefit to the sexual partner as well as the benefit to the HIV-infected person. This is the first randomized clinical trial to definitively indicate that an HIV-infected individual can reduce sexual transmission of HIV to an uninfected partner by beginning antiretroviral therapy sooner. HPTN recognizes the significant contr
'/>"/>

SOURCE HIV Prevention Trials Network
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals Obeticholic Acid (INT-747) in NASH
2. Genus Oncology, LLC Announces Initiation of Phase I Trial of GO-203-2c in Patients With Solid Tumors
3. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
4. Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
5. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
6. Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist
7. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
8. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
9. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
10. Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™
11. Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Reportbuyer.com has added a new market research ... https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... special type of X-ray test used to measure the ... to detect osteopenia or osteoporosis, diseases in which the ... is high. The purpose of bone densitometry is to ...
(Date:7/28/2014)... -- June 28 th , 2014 – Oncolab, the ... cancer test, is making its AACC debut (booth #4051) at ... is a serum-based in vitro immunoassay, has been run for ... in the fight against cancer recurrence. Photo - ... million cancer survivors in the US alone, the race is ...
(Date:7/28/2014)...  Surgical Theater, LLC announced today the addition ... Board. New members include Ori J. Braun ... and New Technologies for Given Imaging Ltd., and ... President and General Manager of Philips Healthcare,s Computer ... technology to brain surgery and has developed software-based ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5
... FRANCISCO, Calif. , March 15 Poniard Pharmaceuticals, ... innovative oncology therapies, today announced the sale of 4,229,000 of ... Ltd. for gross proceeds of approximately $6.3 million , ... committed equity financing facility with Commerce Court.  Poniard intends to ...
... Caliper Life Sciences, Inc. (Nasdaq: CALP ), a ... life sciences research, today announces that it has entered into ... subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by ... District of Texas that claimed that Shimadzu,s MultiNA ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces $6.3 Million Financing 2Poniard Pharmaceuticals Announces $6.3 Million Financing 3Poniard Pharmaceuticals Announces $6.3 Million Financing 4Caliper Settles Outstanding Litigation with Shimadzu 2
(Date:7/28/2014)... 28, 2014 Ticket Down is ... Champions Cup Match between Manchester City and Liverpool FC ... Bronx has hosted countless big events since it opened several ... of the original Yankee Stadium, however, it has been a ... City metro area. , The Yankees Stadium is the ...
(Date:7/28/2014)... UHY LLP, a member of the global ... International Business – Issue 29. This bi-annual publication features ... current business challenges and key issues faced by companies ... following topics:, , Key industry sectors ... the next five years? Where are growth opportunities to ...
(Date:7/28/2014)... students seem to be satisfied with the healthier school lunches ... school officials. , , New meal standards -- issued by ... the fall of 2012. At the time, there was concern ... of their food. But the new study of nearly 600 ... "The updated meals standards are resulting in healthier meals for ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Glutamine is ... and it’s considered to be conditionally essential during times ... is an advanced recovery & Immune System Support. , ... glutamine your body produces, supplementing with additional glutamine may ... waste products in the body, digestion and immune system ...
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
Breaking Medicine News(10 mins):Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 2Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 3Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3
... A hospital group based in McAllen, Texas, has agreed to ... it violated the False Claims Act, the Anti-Kickback Statute and ... compensation to doctors in order to induce them to refer ... today. McAllen Hospitals L.P., d/b/a/ South Texas Health System, is ...
... , - Calls on Congress to Address Long Term ... 30 At a briefing by the Leadership Council of Aging ... Council on Aging (NCOA), applauded the House for making the CLASS ... Health Care for America Act and urged the Senate to include ...
... new drugs in pipeline , FRIDAY, Oct. 30 (HealthDay ... present a major public health problem, said scientists gathering ... Friday. , Chief among the concerns are resistant gram-negative ... and otherwise healthier people. The troubling trend is compounded ...
... more go up, study finds , FRIDAY, Oct. 30 (HealthDay ... dialysis, a U.K. study has found. , Researchers at the ... information on 69 dialysis patients who had traveled in Europe, ... Rim and South Asia. , One person died while traveling, ...
... , BIRMINGHAM, Ala., Oct. 30 WakeMed Health & ... a Letter of Understanding (LOU) under which the two ... http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) , These opportunities may include WakeMed ... Blue Ridge Surgery Center with SCA continuing to manage ...
... new study from a researcher at Harvard University finds that ... while straight men prefer the most feminine-faced women. The ... wired for attraction to sexually dimorphic facesthose with facial features ... The research is currently published online in the journal ...
Cached Medicine News:Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 2Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 3Health News:National Council on Aging's Firman Lauds CLASS Act as Part of House Health Care Bill 2Health News:National Council on Aging's Firman Lauds CLASS Act as Part of House Health Care Bill 3Health News:Antibiotic Resistance Still a Major Public Health Threat 2Health News:Antibiotic Resistance Still a Major Public Health Threat 3Health News:Antibiotic Resistance Still a Major Public Health Threat 4Health News:WakeMed and Surgical Care Affiliates Enter into Venture for Ambulatory Surgery 2Health News:WakeMed and Surgical Care Affiliates Enter into Venture for Ambulatory Surgery 3Health News:For gay and straight men, facial attraction operates similarly 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: